A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers
Clinical trial NCT04384666 · COMPLETED
Trial details
- NCT number
- NCT04384666
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-02
- Primary completion
- 2020-08-05
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.